Cas:606091-64-9 2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide manufacturer & supplier

We serve Chemical Name:2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide CAS:606091-64-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide

Chemical Name:2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide
CAS.NO:606091-64-9
Synonyms:2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide
Molecular Formula:C21H24N4O2S
Molecular Weight:396.50600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:108.30000
Exact Mass:396.16200
LogP:5.17160

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide Use and application,2-{2-[(2-Anilino-2-oxoethyl)sulfanyl]-1H-benzimidazol-1-yl}-N-(2- methyl-2-propanyl)acetamide technical grade,usp/ep/jp grade.


Related News: During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. 4-Methylsulphonyl benzaldehyde manufacturers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. L-4-Nitrophenylalanine methyl ester hydrochloride suppliers Prime Minister Naftali Bennett, launching the campaign, said President Isaac Herzog would be the first to receive the booster, on Friday. Ethyl 2-(1-Imidazolyl)acetate vendor & factory.